Net Cash Provided by (Used in) Operating Activities |
-12.7K |
USD |
+78.7% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
12.9K |
USD |
-87.4% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-149K |
USD |
-545% |
Q2 2023 |
Q1 2025 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Q2 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
117M |
shares |
+81.4% |
Q2 2024 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-107K |
USD |
-888% |
Q2 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
444 |
USD |
-14.3% |
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
625K |
USD |
+251% |
Q1 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
625K |
USD |
+251% |
Q1 2024 |
FY 2024 |
Depreciation |
1.5K |
USD |
|
Q2 2024 |
Q1 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-529K |
USD |
-28.5% |
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
2.98M |
USD |
+251% |
Q1 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
10M |
shares |
+100% |
Q2 2024 |
Q1 2025 |
Preferred Stock, Shares Authorized |
20M |
shares |
|
Q2 2024 |
Q1 2025 |
Additional Paid in Capital |
1.28M |
USD |
+647% |
Q2 2024 |
Q1 2025 |
Preferred Stock, Shares Outstanding |
10M |
shares |
+100% |
Q2 2024 |
Q1 2025 |
Depreciation, Depletion and Amortization |
19.5K |
USD |
+114% |
Q2 2024 |
Q1 2025 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2024 |
Q1 2025 |